These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 24606513)

  • 1. Genetic determinants of HDL metabolism.
    Ossoli A; Gomaraschi M; Franceschini G; Calabresi L
    Curr Med Chem; 2014; 21(25):2855-63. PubMed ID: 24606513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models.
    Rader DJ; Ikewaki K
    Curr Opin Lipidol; 1996 Jun; 7(3):117-23. PubMed ID: 8818507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoprotein quantity or quality for cardiovascular prevention?
    Calabresi L; Gomaraschi M; Franceschini G
    Curr Pharm Des; 2010 May; 16(13):1494-503. PubMed ID: 20196739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage analysis of the genetic determinants of high density lipoprotein concentrations and composition: evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein loci.
    Bu X; Warden CH; Xia YR; De Meester C; Puppione DL; Teruya S; Lokensgard B; Daneshmand S; Brown J; Gray RJ
    Hum Genet; 1994 Jun; 93(6):639-48. PubMed ID: 8005588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between plasma phospholipid transfer protein activity and HDL subclasses among patients with low HDL and cardiovascular disease.
    Cheung MC; Wolfbauer G; Brown BG; Albers JJ
    Atherosclerosis; 1999 Jan; 142(1):201-5. PubMed ID: 9920522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL and atherosclerosis: Insights from inherited HDL disorders.
    Calabresi L; Gomaraschi M; Simonelli S; Bernini F; Franceschini G
    Biochim Biophys Acta; 2015 Jan; 1851(1):13-8. PubMed ID: 25068410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of high-density lipoprotein metabolism.
    Rye KA; Barter PJ
    Circ Res; 2014 Jan; 114(1):143-56. PubMed ID: 24385508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
    Peacock RE; Hamsten A; Johansson J; Nilsson-Ehle P; Humphries SE
    Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A
    Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome.
    Gordon SM; Li H; Zhu X; Tso P; Reardon CA; Shah AS; Lu LJ; Davidson WS
    J Proteomics; 2016 Sep; 146():184-94. PubMed ID: 27385375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein metabolism and the role of apolipoproteins as metabolic programmers.
    Dolphin PJ
    Can J Biochem Cell Biol; 1985 Aug; 63(8):850-69. PubMed ID: 3904949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the regulation of HDL metabolism and reverse cholesterol transport.
    Lewis GF; Rader DJ
    Circ Res; 2005 Jun; 96(12):1221-32. PubMed ID: 15976321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of structural stability with functional remodeling of high-density lipoproteins: the importance of being disordered.
    Guha M; Gao X; Jayaraman S; Gursky O
    Biochemistry; 2008 Nov; 47(44):11393-7. PubMed ID: 18839964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations.
    Assmann G; von Eckardstein A; Funke H
    Circulation; 1993 Apr; 87(4 Suppl):III28-34. PubMed ID: 8462178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural stability and functional remodeling of high-density lipoproteins.
    Gursky O
    FEBS Lett; 2015 Sep; 589(19 Pt A):2627-39. PubMed ID: 25749369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
    Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
    J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDL metabolism and its role in lipid transport.
    Miller NE
    Eur Heart J; 1990 Dec; 11 Suppl H():1-3. PubMed ID: 2073908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein distribution and serum concentrations of 7α-hydroxy-4-cholesten-3-one and bile acids: effects of monogenic disturbances in high-density lipoprotein metabolism.
    Steiner C; Holleboom AG; Karuna R; Motazacker MM; Kuivenhoven JA; Frikke-Schmidt R; Tybjaerg-Hansen A; Rohrer L; Rentsch KM; Eckardstein Av
    Clin Sci (Lond); 2012 Apr; 122(8):385-96. PubMed ID: 22010943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine A transfer between high- and low-density lipoproteins: independent from lipid transfer protein I-facilitated transfer of lipoprotein-coated phospholipids because of high affinity of cyclosporine a for the protein component of lipoproteins.
    Kwong M; Sivak O; Kwong EH; Wasan KM
    J Pharm Sci; 2001 Sep; 90(9):1308-17. PubMed ID: 11745783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.